NIPD Genetics receives SME of 2012 AwardNIPD Genetics is proud to announce it has been awarded Best SME (Small and Medium-sized Enterprise) of 2012 during the IN Business Awards, the purpose of which is to recognize excellence in the business field in Cyprus. The award was accepted by the Chief Executive Director, Prof. Philippos Patsalis.
|
InvestorsNIPD Genetics Limited is currently raising capital of up to four million Euro. This second round of equity financing also includes follow-on commitments from existing investors. The company will use these funds to expand its team and increase its capacity to accelerate completion of its upcoming large clinical validation study and commercial introduction of its NIPD21 test for Down syndrome. |
